[Alfuzosin. A new selective alpha 1 receptor antagonist for symptomatic medical treatment of benign prostatic hypertrophy prior to surgery].
Centralsygehuset Hillerød, organkirurgisk afdeling A.
B J
BJ
Hansen
H H
HH
Meyhoff
D000317:Adrenergic alpha-Antagonists / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011292:Premedication; D011300:Preoperative Care; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000601:surgery; D011799:Quinazolines / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D011799:Quinazolines; C047638:alfuzosin
Alfuzosin. En ny selektiv alfa-1-receptorantagonist, registreret til symptomatisk medicinsk behandling af benign prostatahypertrofi i perioden inden operation.